Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Kim (Jeju, Republic of Korea), H. Jwa (Jeju, Republic of Korea). The clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: A systematic review and meta-analysis. 1341

Member's Comments

No comment yet.

Related content which might interest you: Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review Source: Eur Respir Rev, 29 (157) 190158; 10.1183/16000617.0158-2019 Year: 2020 The effect of anti-acid therapy on survival in idiopathic pulmonary fibrosis: a methodological review of observational studies Source: Eur Respir J, 51 (6) 1800376; 10.1183/13993003.00376-2018 Year: 2018 Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review Source: Eur Respir J 2015; 46: 1113-1130 Year: 2015 Pulmonary hypertension in COPD patients: a systematic review and meta-analysis Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Safety and benefits of beta-blockers in chronic obstructive pulmonary disease: a review of current evidence and meta-analysis Source: International Congress 2018 – Cardiovascular morbidities in COPD Year: 2018 A systematic review and individual participant data meta-analysis of MMP-7 and outcomes in idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia Year: 2021 Treatment of pulmonary hypertension associated with COPD: a systematic review Source: ERJ Open Res, 8 (1) 00348-2021; 10.1183/23120541.00348-2021 Year: 2022 Assessing the treatment effect from multiple trials in idiopathic pulmonary fibrosis Source: Eur Respir Rev 2012; 21: 147-151 Year: 2012 Assessment of recent evidence for the management of patients with systemic sclerosis-associated interstitial lung disease: a systematic review Source: ERJ Open Res, 7 (1) 00235-2020; 10.1183/23120541.00235-2020 Year: 2021 Prognostic significance of autoantibodies for idiopathic pulmonary fibrosis: a systematic review and meta-analysis Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF) Year: 2018 Generalisability of recent clinical trials in idiopathic pulmonary fibrosis to everyday clinical practice Source: International Congress 2015 – Treatment of IPF Year: 2015 The effect of methlyxanthines as adjunct to corticosteroids among chronic obstructuve pulmonary disease patients in acute exacerbation: a systematic review and meta-analysis Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review Source: Eur Respir J 2015; 46: 795-806 Year: 2015 STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Systematic review of content and quality of idiopathic pulmonary fibrosis review articles Source: ERJ Open Res, 4 (4) 00156-2018; 10.1183/23120541.00156-2018 Year: 2018 A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Source: Eur Respir J 2015; 46: 243-249 Year: 2015 A systematic review of overlapping microRNA patterns in systemic sclerosis and idiopathic pulmonary fibrosis Source: Eur Respir Rev, 26 (144) 160125; 10.1183/16000617.0125-2016 Year: 2017 Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis Source: Eur Respir J, 54 (6) 1901188; 10.1183/13993003.01188-2019 Year: 2019 Oral theophylline benefits stable 'irreversible' chronic obstructive pulmonary disease: a systematic review and meta-analysis Source: Eur Respir J 2002; 20: Suppl. 38, 374s Year: 2002 Pirfenidone treatment for idiopathic pulmonary fibrosis (IPF): a comprehensive analysis of safety Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009